Stakeholders ask for flexibility, more examples in FDA guidance on overall survival in cancer trials
Stakeholders asked the US Food and Drug Administration for more examples in comments on a recently issued guidance on the use of overall survival as an endpoint in oncology drug clinical trials. They ...
"I’d like less flexibility," said no one, ever. Today’s leaders mostly acknowledge that employee needs are diverse and ever-evolving, shaped by societal shifts such as global mobility, social ...
COVID-19 has had a significant impact on all facets of our lives, including the ways we work and our work-life priorities. One common theme in the employment trends to emerge during COVID-19 is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results